{"id":"W4389503869","doi":"10.1016/j.annonc.2023.10.123","title":"Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Sanofi Genzyme; Genentech; Castle Biosciences; Incyte; Array BioPharma; Regeneron Pharmaceuticals; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Tolerability; Interquartile range; Clinical endpoint; Internal medicine; Gastroenterology; Phases of clinical research; Progression-free survival; Surgery; Oncology; Toxicity; Adverse effect; Overall survival; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006987621,0.0002060141,0.0006670891,0.000528336,0.00004225917,0.000003194105,0.0001792838,0.000144932,0.00001267565],"category_scores_gemma":[0.0001770094,0.0001788785,0.0002100975,0.001171286,0.0002307697,0.000005050126,0.0002032071,0.00011277,0.000004266994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001385506,"about_ca_system_score_gemma":0.000272292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008585038,"about_ca_topic_score_gemma":0.000449193,"domain_scores_codex":[0.99814,0.0001881542,0.0006519369,0.0004446718,0.000186122,0.0003891118],"domain_scores_gemma":[0.9988735,0.0001088764,0.000311427,0.0003773177,0.000252975,0.00007591762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01286389,0.00418016,0.03123499,0.0003196932,0.002505639,0.0009065496,0.004841415,0.003650912,0.91932,0.00002472055,0.007455293,0.01269677],"study_design_scores_gemma":[0.007077154,0.01765824,0.03215542,0.00003865165,0.0004709972,0.000004810378,0.0009436343,0.0003638027,0.9310925,0.00004173021,0.009773949,0.0003791395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973665,0.0006163745,0.00004485581,0.0004177493,0.00006214609,0.0001689934,0.0003692926,0.000008518434,0.0009456012],"genre_scores_gemma":[0.998733,0.0001118902,0.0003097185,0.0001956303,0.00004905104,0.00005134956,0.0002666034,0.00002004837,0.0002626911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01347808,"threshold_uncertainty_score":0.7294452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07055745788880101,"score_gpt":0.3505858826284589,"score_spread":0.2800284247396578,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}